Medical Cannabis for Chronic Prostatitis / CPPS — Switzerland 2026

Chronic prostatitis / chronic pelvic pain syndrome is hard to treat in urology. Cannabinoids reduce neuropathic pelvic pain — cheaper for members.

Chronic prostatitis / CPPS (NIH category III) affects 8–15 % of men. Antibiotics rarely help, α-blockers only partially. Cannabinoids act on CB1/CB2 in the urogenital plexus, reducing neuropathic pelvic pain. Tripp 2019 & Vela 2017: CBD-rich preparations improve pain and QoL. CannabisClub members: 50 CHF flat instead of 190.

What the studies show

Tripp 2019 (cohort, n=339): 43 % of CPPS men on cannabis reported significant pain reduction.

Vela 2017 (RCT, endometriosis-adjacent): CBD 20 mg reduced neuropathic pelvic pain by 40 %.

Preparations & dosing

CBD oil 25–75 mg twice daily as base — anti-inflammatory, no high.

THC 2.5–5 mg evenings for sleep disturbance from pain.

Save as a CannabisClub member

Urologists charge 190–250 CHF for cannabis consult, often with waitlist. Members: 50 CHF flat, telemedicine possible. Registration free.

FAQ

Does cannabis replace my α-blockers?

No. Add-on for insufficient efficacy or side effects (ejaculatory disorders especially).

What does membership save?

50 CHF instead of 190 CHF per consultation. Registration free.

Does insurance cover it?

Rarely — CPPS is not a standard art. 71a indication. Usually out of pocket.

Cannabis for Chronic Prostatitis (CP/CPPS) — Prescription Switzerland 2026 (Members 50 CHF)